FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

2847011000036107: ranibizumab (AU substance)

Status: current, Primitive. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
178121011000036119 ranibizumab (AU substance) en Fully specified name Active Case sensitive Australian Medicines Terminology module
178122011000036113 ranibizumab en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
ranibizumab Is a medicinal substance true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Lucentis 2.3 mg/0.23 mL injection, 0.23 mL vial has intended active ingredient True ranibizumab Inferred relationship Some 584089342
Lucentis 3 mg/0.3 mL injection, 0.3 mL vial has intended active ingredient True ranibizumab Inferred relationship Some 262824562
Lucentis 2.3 mg/0.23 mL injection, 0.23 mL vial has Australian BoSS True ranibizumab Inferred relationship Some 584089342
Lucentis 1.65 mg/0.165 mL injection, 0.165 mL syringe has Australian BoSS True ranibizumab Inferred relationship Some 1811582890
ranibizumab has intended active ingredient True ranibizumab Inferred relationship Some 1
ranibizumab 3 mg/0.3 mL injection, vial has intended active ingredient True ranibizumab Inferred relationship Some 636434450
ranibizumab 3 mg/0.3 mL injection, vial has Australian BoSS True ranibizumab Inferred relationship Some 636434450
ranibizumab 2.3 mg/0.23 mL injection, vial has intended active ingredient True ranibizumab Inferred relationship Some 1808999480
ranibizumab 2.3 mg/0.23 mL injection, vial has Australian BoSS True ranibizumab Inferred relationship Some 1808999480
ranibizumab 1.65 mg/0.165 mL injection, syringe has intended active ingredient True ranibizumab Inferred relationship Some 811762776
ranibizumab 1.65 mg/0.165 mL injection, syringe has Australian BoSS True ranibizumab Inferred relationship Some 811762776
Lucentis 1.65 mg/0.165 mL injection, 0.165 mL syringe has intended active ingredient True ranibizumab Inferred relationship Some 1811582890
Lucentis 3 mg/0.3 mL injection, 0.3 mL vial has Australian BoSS True ranibizumab Inferred relationship Some 262824562

This concept is not in any reference sets

Back to Start